Patent details

EP2663310 Title: ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING TASOCITINIB

Basic Information

Publication number:
EP2663310
PCT Application Number:
PCT/EP/2012/000353
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127032407
PCT Publication Number:
WO/2012/100949
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING TASOCITINIB
French Title of Invention:
FORMES GALÉNIQUES ORALES À LIBÉRATION MODIFIÉE COMPRENANT DU TASOCITINIB
German Title of Invention:
ORALE DARREICHUNGSFORMEN FÜR MODIFIZIERTE FREISETZUNG MIT TASOCITINIB
SPC Number:

Dates

Filing date:
26/01/2012
Grant date:
14/05/2014
EP Publication Date:
14/05/2014
PCT Publication Date:
02/08/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/11/2013
EP B1 Publication Date:
14/05/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/01/2015
Expiration date:
26/01/2032
Renunciation date:
Revocation date:
18/10/2016
Annulment date:

Owner

From:
18/07/2014
 
 

Name:
ratiopharm GmbH
Address:
Graf-Arco-Strasse 3, 89079 Ulm, Germany (DE)

Inventor

1

Name:
STEFAN Ralph
Address:
Germany (DE)

2

Name:
SIEVERT Frank
Address:
Germany (DE)

Priority

Priority Number:
11000677
Priority Date:
27/01/2011
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 9/16;

Publication

European Patent Bulletin

Issue number:
201715
Publication date:
12/04/2017
Description:
Revocation of the European patent
Filing date Document type Number of pages